Pharmacogenetic effect of the stromelysin (MMP3) polymorphism on stroke risk in relation to antihypertensive treatment: the genetics of hypertension associated treatment study.
Posted: Feb 24th, 2015
ALLHAT/GENHAT Publications 
Pharmacogenetic associations of MMP9 and MMP12 variants with cardiovascular disease in patients with hypertension.
Posted: Feb 24th, 2015
Gene panels to help identify subgroups at high and low risk of coronary heart disease among those randomized to antihypertensive treatment: the GenHAT study.
Posted: Feb 24th, 2015
Pharmacogenetic association of NOS3 variants with cardiovascular disease in patients with hypertension: the GenHAT study.
Posted: Feb 24th, 2015
RYR3 gene polymorphisms and cardiovascular disease outcomes in the context of antihypertensive treatment.
Posted: Feb 24th, 2015
Pharmacogenetic effects of ‘candidate gene complexes’ on stroke in the GenHAT study.
Posted: Feb 24th, 2015